Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

TVF Communications

- PMLiVE

New Webinar: Supercharge Pharma Med Ed with AI

Unlock the power of AI to transform pharma medical education, training, and critical insight gathering. Discover how next-gen AI tech such as AI Avatars, enable hyper-realistic training, enhance engagement, and...

Impetus Digital

- PMLiVE

Havas Lynx Welcomes New Leadership Hires

Havas Lynx announces the appointment of Ayesha Walawalkar as Chief Strategy Officer, and Talin Apkarian as Havas Lynx Hudson Managing Director.

Havas Lynx

- PMLiVE

Johnson & Johnson’s Darzalex approved by EC as first treatment for high-risk SMM

The early precursor of active multiple myeloma accounts for around 15% of all new multiple myeloma cases

- PMLiVE

LEO’s Anzupgo granted FDA approval to treat moderate-to-severe chronic hand eczema

The cream is now the first treatment approved by the regulator specifically for this patient population

- PMLiVE

Abivax shares positive late-stage results for obefazimod in ulcerative colitis

Inflammatory bowel disease affects nearly one in every 100 people in the US

- PMLiVE

Rain Free Days: A Migraine App Shaped by Real Experiences

Rain Free Days® is a free migraine support app created by Teva, 11 London, and the migraine community. It helps users track symptoms, spot patterns, and access personalised resources like...

11 London

- PMLiVE

Honoring the Legacy of Dr. Robert Sidbury, MD, MPH

We are deeply saddened by the recent passing of Dr. Robert Sidbury. Dr. Sidbury was a visionary in pediatric dermatology whose dedication to advancing patient care inspired clinicians, researchers, and...

Medscape Education

- PMLiVE

AstraZeneca unveils plans to boost US footprint with $50bn investment

The funds will go towards establishing a multi-billion dollar drug substance facility in Virginia

- PMLiVE

Roche’s Itovebi granted EC approval to treat advanced breast cancer patients

Hormone receptor-positive breast cancer accounts for around 70% of all breast cancer cases

- PMLiVE

NICE recommends ALK’s immunotherapy to target underlying cause of hay fever

An estimated 26,800 people in England with moderate-to-severe cases could benefit from Itulazax

- PMLiVE

FDA appoints George Tidmarsh as director of CDER

Tidmarsh has most recently been serving as adjunct professor of paediatrics and neonatology at Stanford University

Patient talking to HCP

Why fresh patient voices are critical to improve clinical trials outcomes

Discover why diverse patient voices, especially first-time participants, are key to improving clinical trials. Boost recruitment, retention, and patient-centric research.

Cuttsy + Cuttsy

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links